![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current RKDA market cap is 3.34M. The company's latest EPS is USD -12.5917 and P/E is -0.24.
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 1M | 1.51M | 1.39M | 1.26M | 1.17M |
Operating Income | -5.76M | -4.07M | -3.8M | -2.74M | -3.37M |
Net Income | -4.24M | -9.38M | 823k | -2.57M | -2.85M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 2.17M | 8.03M | 6.78M | 9.96M | 5.33M |
Operating Income | -19.38M | -21.59M | -35.24M | -20.34M | -13.98M |
Net Income | -28.81M | -4.66M | -14.66M | -15.38M | -13.98M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 28.92M | 30.41M | 26.8M | 23.47M | 19.71M |
Total Liabilities | 8.02M | 13.72M | 9.07M | 8.07M | 7M |
Total Equity | 20.9M | 16.69M | 17.73M | 15.4M | 12.7M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 32.57M | 47.35M | 43.92M | 28.92M | 19.71M |
Total Liabilities | 24.25M | 18.8M | 12.72M | 8.02M | 7M |
Total Equity | 8.33M | 28.55M | 31.2M | 20.9M | 12.7M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -13.98M | -3.47M | -8.26M | -11.15M | -15.29M |
Investing | 1.42M | 315k | -4.4M | -4.4M | -4.34M |
Financing | 4.52M | 5.51M | 5.51M | 5.51M | 5.51M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -17.2M | -30.22M | -25.87M | -13.98M | -15.29M |
Investing | -8.37M | 17.28M | 16.61M | 1.42M | -4.34M |
Financing | 21.99M | 20.56M | 21.9M | 4.52M | 5.51M |
Market Cap | 3.34M |
Price to Earnings Ratio | -0.24 |
Price to Sales Ratio | 0.63 |
Price to Cash Ratio | 0.51 |
Price to Book Ratio | 0.26 |
Dividend Yield | - |
Shares Outstanding | 1.11M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0.27 (8.49%) |
Company Name | Arcadia Biosciences Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.arcadiabio.com |
Industry | pesticides, agric chems, nec (2879) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions